Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Signaling via growth factor receptors, including the
epidermal growth factor (EGF) receptor
, is key to various cellular processes, such as proliferation, cell survival, and cell migration. In a variety of human diseases such as cancer, aberrant expression and activation of growth factor receptors can lead to disturbed signaling. Intracellular trafficking is crucial for proper signaling of growth factor receptors. As a result, the level of cell surface expression of growth factor receptors is an important determinant for the outcome of downstream signaling. BAR domain-containing proteins represent an important family of proteins that regulate membrane dynamics. In this study, we identify a novel role for the F-BAR protein
PACSIN2
in the regulation of EGF receptor signaling. We show that internalized EGF as well as the (activated) EGF receptor translocated to
PACSIN2
-positive endosomes. Furthermore, loss of
PACSIN2
increased plasma membrane expression of the EGF receptor in resting cells and increased EGF-induced phosphorylation of the EGF receptor. As a consequence, EGF-induced activation of Erk and Akt as well as cell proliferation were enhanced in
PACSIN2
-depleted cells. In conclusion, this study identifies a novel role for the F-BAR-domain protein
PACSIN2
in regulating EGF receptor surface levels and EGF-induced downstream signaling.
...
PMID:The F-BAR protein PACSIN2 regulates epidermal growth factor receptor internalization. 2312 63